Doctors lambaste federal process for distributing Covid-19 drug remdesivir

[SheltieLover]

https://www.statnews.com/2020/05/06/doctors-lambaste-federal-process-for-distributing-covid-19-drug-remdesivir/

Hospitals and physicians around the country are sharply criticizing the federal government for the uneven and opaque way it is distributing its supply of the Covid-19 drug remdesivir.

The experimental drug received an emergency use authorization from the Food and Drug Administration last week, after preliminary data from a clinical trial showed that it reduced how long it took hospitalized Covid-19 patients to recover. Now, as the drug’s producer, Gilead Sciences, tries to ramp up production, the U.S. government is starting to distribute the limited number of vials that aren’t needed for ongoing research, so that patients can start to see the benefit outside of clinical trials.

About two dozen hospitals are believed to have been chosen to receive the drug so far, but clinicians told STAT it is unclear why some medical centers were chosen to receive coveted doses while others weren’t — and who is making those decisions in the first place.

Much more at link.

[Phoenix61]

1. Gee, I wonder what the criteria could be?

Big fat repub donor on the board of directors maybe? Just spitballing.